<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-08-20T02:11:28Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/93325" metadataPrefix="rdf">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/93325</identifier><datestamp>2025-03-18T14:05:11Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:docta.ucm.es:20.500.14352/93325">
      <dc:title>Magnetic Janus micromotors for fluorescence biosensing of tacrolimus in oral fluids</dc:title>
      <dc:creator>Glahn Martínez, Ana Bettina</dc:creator>
      <dc:creator>Jurado-Sánchez, Beatriz</dc:creator>
      <dc:creator>Benito Peña, María Elena</dc:creator>
      <dc:creator>Escarpa, Alberto</dc:creator>
      <dc:creator>Moreno Bondi, María Cruz</dc:creator>
      <dc:description>Tacrolimus (FK506) is a macrolide lactone immunosuppressive drug that is commonly used in transplanted patients to avoid organ rejection. FK506 exhibits high inter- and intra-patient pharmacokinetic variability, making monitoring necessary for organ graft survival. This work describes the development of a novel bioassay for monitoring FK506. The bioassay is based on using polycaprolactone-based (PCL) magnetic Janus micromotors and a recombinant chimera receptor that incorporates the immunophilin tacrolimus binding protein 1A (FKBP1A) tagged with Emerald Green Fluorescent Protein (EmGFP). The approach relies on a fluorescence competitive bioassay between the drug and the micromotors decorated with a carboxylated FK506 toward the specific site of the fluorescent immunophilin. The proposed homogeneous assay could be performed in a single step without washing steps to separate the unbound receptor. The proposed approach fits the therapeutic requirements, showing a limit of detection of 0.8 ng/mL and a wide dynamic range of up to 90 ng/mL. Assay selectivity was evaluated by measuring the competitive inhibition curves with other immunosuppressive drugs usually co-administered with FK506. The magnetic propulsion mechanism allows for efficient operation in raw samples without damaging the biological binding receptor (FKBP1A-EmGFP). The enhanced target recognition and micromixing strategies hold considerable potential for FK506 monitoring in practical clinical use.</dc:description>
      <dc:date>2024-01-16T11:22:20Z</dc:date>
      <dc:date>2024-01-16T11:22:20Z</dc:date>
      <dc:date>2024</dc:date>
      <dc:type>journal article</dc:type>
      <dc:identifier>Glahn-Martínez, Bettina, et al. «Magnetic Janus Micromotors for Fluorescence Biosensing of Tacrolimus in Oral Fluids». Biosensors and Bioelectronics, vol. 244, enero de 2024, p. 115796. https://doi.org/10.1016/j.bios.2023.115796.</dc:identifier>
      <dc:identifier>0956-5663</dc:identifier>
      <dc:identifier>10.1016/j.bios.2023.115796</dc:identifier>
      <dc:identifier>https://hdl.handle.net/20.500.14352/93325</dc:identifier>
      <dc:identifier>https://doi.org/10.1016/j.bios.2023.115796</dc:identifier>
      <dc:identifier>https://www.sciencedirect.com/science/article/pii/S0956566323007388</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:relation>RTI2018-096410-B-C21</dc:relation>
      <dc:relation>PID2021-127457OBC21</dc:relation>
      <dc:relation>PID2020-118154 GB-I00</dc:relation>
      <dc:relation>TED2021132720B–I00</dc:relation>
      <dc:relation>CM/JIN/ 2021-012 (B.J.S.)</dc:relation>
      <dc:relation>TRANSNANOAVANSENS, S2018/NMT-4349 (A.E.)</dc:relation>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
      <dc:rights>open access</dc:rights>
      <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
      <dc:publisher>Elsevier</dc:publisher>
   </ow:Publication>
</rdf:RDF></metadata></record></GetRecord></OAI-PMH>